We would like to thank each of our sponsors for their generous support - as without them this event would not be possible.
For more information on the sponsor opportunities available, contact Michelle Legrand at Michelle.Legrand@pharmatimes.com
Bowel Research UK is funding life-changing research into bowel cancer and other bowel diseases.
Every year, over 42,000 people in the UK are diagnosed with bowel cancer, and one million live with other life-changing inflammatory bowel diseases like Crohn’s and ulcerative colitis.
There is hope for a cure for bowel cancer and bowel disease, and it’s called research.
Research leads to more effective treatments, improved surgery outcomes, better care and support, and most importantly, a higher quality of life and better chances of survival.
Bowel Research UK is the only UK charity dedicated to funding research into both bowel cancer and bowel diseases.
Our focus is on early career research – we act as the catalyst that identifies the seeds of future ideas and support them with PhDs and small grants to kickstart early research development. Through our ‘Hard to Fund’ Fund, we're making an impact in areas of bowel health that have been overlooked or historically underfunded. For every £1 we invest in research, we help secure an additional £3 in funding, ensuring we identify research that truly makes a difference.
By supporting cutting-edge treatments and investing in the best science, we’re saving and improving lives.
The Encephalitis Society is the global authority on encephalitis (inflammation of the brain) and the only non-profit in the world providing direct support and information to people affected by all types of encephalitis, raising awareness about the condition, and furthering our understanding of encephalitis through promoting and collaborating on research.
Since our inception in 1994 we have been committed to exponentially expanding our reach and have developed into a unique global resource for people all over the world directly affected by encephalitis, their family members, those left bereaved by the condition, and the scientific, medical and health professionals supporting them. To this end, we provide an expert-led support service, run an award-winning, global awareness campaign – World Encephalitis Day – and host the go-to conference on the latest research on encephalitis for research professionals across the world.
The work of the Encephalitis Society is also supported by a 24-member strong advisory panel of world class neurology experts – clinicians and researchers at the forefront of our understanding of encephalitis, inclusive of our Chief Executive, Dr Ava Easton, who is an encephalitis expert and has published several papers and a book “Life After Encephalitis” on aspects of encephalitis and its after-effects.
A uniquely placed strategy consultancy dedicated to healthcare, Redbow works hand in hand with its clients across many areas of organizational strategy worldwide. Assignments span strategy development, long range and brand planning to developing marketing academies and helping to build cohesive high performing teams.
Redbow specialises in the use of gaming methodologies and simulation for strategy development and organisational engagement as well as developing and embedding bespoke strategic planning processes for many clients.
Jonathan Dancer, Managing Director is a firm believer in the power of teams, and whilst most projects focus on the concrete end of strategy and implementation, many revolve additionally around the creation and maintenance of healthy teams that can take their organisations forward.
